Accelrys Unveils Post-Symyx-Merger Business Strategy Amid 42 Percent Rise in Q4 Revenues

Accelrys' fourth-quarter revenues rose 42 percent and the firm announced that it has completed its integration activities with Symyx "on schedule" and within its planned budget.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.